{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:54:01Z","timestamp":1773244441758,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The National Institute of health and Care Excellence issued guidelines on familial breast cancer screening in 2004. Such guidelines should be uniformly implemented to ensure that members of the same family with the same level of risk, but living in different areas, have the same access to screening. We assessed uptake by creating a short, six question online survey designed to assess compliance in each regional area. We used this to conduct a survey of all 22 regional genetics services. There was a 100% response to the survey allowing a complete map to be created. The devolved nations had near complete compliance with the sole exception of SW Scotland, but in England the picture was fragmented with regions representing a combined population of 26.6 million (48%) not implementing the full NICE recommendations. Fifteen years after the publication of the original guidelines, major inequity in provision for screening still occurs and a postcode lottery exists for the management of women from families with a history of breast cancer. We estimate that up to 73 preventable breast cancer deaths occur each year due to the current inequity of access. It may be time to consider alternative funding and implementation models to ensure consistent access across the country.<\/jats:p>","DOI":"10.1038\/s41416-019-0631-2","type":"journal-article","created":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T19:02:57Z","timestamp":1574622177000},"page":"329-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication"],"prefix":"10.1038","volume":"122","author":[{"name":"Cancer Genetics Group clinical leads","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Gareth","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"631_CR1","doi-asserted-by":"crossref","unstructured":"Colbrook, P. Can you ignore guidelines? BMJ 330, s143 (2005).","DOI":"10.1136\/bmj.330.7495.s143-a"},{"key":"631_CR2","unstructured":"Breast Screening Programme 2017\u201318. NHS Breast Screening Programme Report 2017\u201318. (2019). https:\/\/digitalnhsuk\/data-and-information\/publications\/statistical\/breast-screening-programme."},{"key":"631_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","volume":"16","author":"TB Bevers","year":"2018","unstructured":"Bevers, T. B., Helvie, M., Bonaccio, E., Calhoun, K. E., Daly, M. B., Farrar, W. B. et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Canc Netw. 16, 1362\u20131389 (2018).","journal-title":"J. Natl Compr. Canc Netw."},{"key":"631_CR4","unstructured":"NABON-CBO. Guideline for breast cancer. http:\/\/www.oncolinenl\/mammacarcinoom (2012)."},{"key":"631_CR5","unstructured":"Eisinger, F., Alby, N., Bremond, A., Dauplat, J., Espie, M. & Janiaud, P. et al. INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and\/or ovarian cancer. Ann. Genet. 42, 51\u201364 (1999)."},{"key":"631_CR6","unstructured":"McIntosh, A. S., C.; Evans, G. Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer, London: National Collaborating Centre for Primary Care\/University of Sheffield. NICE guideline CG14, CG41,CG164. updated 2006, 2013, 2017, www.nice.org.uk (2004)."},{"key":"631_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/135952201753337086","volume":"6","author":"J Mackay","year":"2001","unstructured":"Mackay, J., Rogers, C., Fielder, H., Blamey, R., Macmillan, D., Boggis, C. et al. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J. Epidemiol. Biostat. 6, 365\u2013369 (2001).","journal-title":"J. Epidemiol. Biostat."},{"key":"631_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1470-2045(10)70263-1","volume":"11","author":"FH01-teams.","year":"2010","unstructured":"FH01-teams. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol. 11, 1127\u20131134 (2010).","journal-title":"Lancet Oncol."},{"key":"631_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1940-6207.CAPR-14-0037","volume":"7","author":"DG Evans","year":"2014","unstructured":"Evans, D. G., Brentnall, A. R., Harvie, M., Dawe, S., Sergeant, J. C., Stavrinos, P. et al. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev. Res (Philos.). 7, 993\u20131001 (2014).","journal-title":"Cancer Prev. Res (Philos.)."},{"key":"631_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66646-9","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach, M. O., Boggis, C. R., Dixon, A. K., Easton, D. F., Eeles, R. A., Evans, D. G. et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365, 1769\u20131778 (2005).","journal-title":"Lancet"},{"key":"631_CR11","unstructured":"NHSBSP74. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/766128\/nhsbsp74.pdf. (2013)."},{"key":"631_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eclinm.2019.01.005","volume":"7","author":"DG Evans","year":"2019","unstructured":"Evans, D. G., Thomas, S., Caunt, J., Burch, A., Brentnall, A. R., Roberts, L. et al. Final results of the prospective FH02 mammographic surveillance study of women aged 35\u201339 at increased familial risk of breast cancer. EClinicalMedicine 7, 39\u201346 (2019).","journal-title":"EClinicalMedicine"},{"key":"631_CR13","first-page":"665","volume":"104","author":"EW Carlton","year":"2018","unstructured":"Carlton, E. W., Pickering, J. W., Greenslade, J., Cullen, L., Than, M., Kendall, J. et al. Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy. Heart 104, 665\u2013672 (2018).","journal-title":"Heart"},{"key":"631_CR14","unstructured":"Duffy, S. W., Mackay, J., Thomas, S., Anderson, E., Chen, T. H., Ellis, I. et al. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol. Assess. 17, 1\u201395 (2013)."},{"key":"631_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D. et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin. 57, 75\u201389 (2007).","journal-title":"CA Cancer J. Clin."},{"key":"631_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1055-9965.EPI-12-0967","volume":"22","author":"JW Miller","year":"2013","unstructured":"Miller, J. W., Sabatino, S. A., Thompson, T. D., Breen, N., White, M. C., Ryerson, A. B. et al. Breast MRI use uncommon among U.S. women. Cancer Epidemiol. Biomark. Prev. 22, 159\u2013166 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0631-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0631-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0631-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:06:08Z","timestamp":1684602368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0631-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,4]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0631-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"D.G.E. is supported by the NIHR Manchester Biomedical Research centre (IS-BRC-1215-20007). M.T. is supported by the NIHR Cambridge Biomedical Research centre.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All data are contained within the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}